Mitomycin C trabeculectomy in eyes with cicatricial conjunctiva.
OBJECTIVE
To demonstrate favorable outcome of mitomycin C-augmented trabeculectomy in eyes with broad cicatricial conjunctiva created by previous surgeries.


METHODS
Forty-six eyes (40 patients) with extensive conjunctival scarring that had undergone mitomycin C trabeculectomy were reviewed retrospectively.


RESULTS
After a mean follow-up +/- SD of 13.7 +/- 7.8 months (range, 6 to 36 months), intraocular pressure was well controlled, below or equal to 16 mm Hg and 21 mm Hg, respectively, in 33 (72%) and 44 (96%) of the 46 eyes. In all eyes, a functional filtering bleb was present during the follow-up periods.


CONCLUSIONS
Mitomycin C trabeculectomy after dissection of conjunctival scar tissue may be useful for treating refractory glaucoma.
Honjo
M
M
Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Japan.
Tanihara
H
H
Inatani
M
M
Honda
Y
Y
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017024:Chemotherapy, Adjuvant; D002921:Cicatrix / Q000150:complications / Q000601:surgery*; D003229:Conjunctival Diseases / Q000150:complications / Q000601:surgery*; D005500:Follow-Up Studies; D005901:Glaucoma / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D008875:Middle Aged; D016685:Mitomycin / Q000627:therapeutic use*; D014130:Trabeculectomy
D016685:Mitomycin